NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want ...

Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...

The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...

Biomedical concepts by CDISC are tailored to ensure data consistency, and link information throughout the data pipeline.